Research Findings And Presentation In Mobile User Experience On Applications And Widgets

PRLog (Press Release) – Sep 29, 2009 – Philip Rhodes, Managing Director of fhios, the Customer Experience Research and Design agency gave a presentation “Mobile user experience on applications and widgets” at “Over the Air” the mobile developer event that covers the cutting edge of current mobile development.
The presentation included a case study exploring how research throughout the design process can lead to innovations in mobile application design which explored recent research findings into the mobile customer experience, detailing how mobile applications must not only have ‘usability’, but must also be ‘engaging’ to ensure that users want to use them time and time again.
fhios’ presentation was designed to show developers that an understanding of the digital customer experience requires deep insights into customer motivations and preference. Providing solutions and understanding into customer expectations and the ‘informational landscape’ in which the user exists, is probably the only way such applications can be designed successfully.
To hear more about the research findings or to learn more about mobile user experience please contact fhios on 0207 886 8245 or email info@fhios.co.uk.
About fhios
fhios is a leading international customer experience research consultancy that was founded in 2002 and have successfully conducted over 400 customer experience and usability research projects across over 35 countries, with many brand perception, customer segmentation, concept & design validation, competitive benchmarking, online communities and user needs projects to provides its clients such as Orange, O2, Samsung, Pay Pal, Motorola, Hilton and Shell/Ferrari with the insight to understand customers needs, goals, expectations, behaviours and experience levels when they engage with them and their competitors.
About the Author
Dr. Philip Rhodes is the founder and Managing Director of fhios an international Customer Experience Research and Design agency, with offices in London, Singapore and Brazil. Philip has worked for more than 10 years in the mobile industry, working with mobile manufacturers, operators and application designers/developers. During that time we have seen that today’s digital life is actually complicating life, leading users to demand greater simplicity. There is in fact a contradiction between the potential options of new technologies, i.e. digital freedom – and the demands of customers to manage the proliferation of these options.
Contact
Email: info@fhios.com
Tel: 0207 886 8241
Web: www.fhios.com
Web Brazil: http://www.fhios.com.br/
Blog: www.fhiosinsights.com
Facebook: www.facebook.com/pages/London-United-Kingdom/fhios/67763082453
Twitter: http://twitter.com/fhios
For more articles or further information about fhios and our full service offering, contact Andrew Horsfall by telephone on 0207 886 8245 or by e-mail at ahorsfall@fhios.com.

# # #

International company with extensive experience with design, development + assessment of interactive applications. fhios have conducted over 300 customer experience research, IA design + usability projects in over 30 countries across all industry sectors.

Drug-Eluting Stents Dominate Coronary Market, For Now

PRLog (Press Release) – Sep 09, 2009 – The global market for coronary stents is owned largely by drug-eluting stents (DES), but the size of the patient pool, the drive for lowered cost, ever-increased efficacy and less trauma are spawning the development of multiple new technologies in coronary stents and competitive anti-restenosis technologies. The global market, products, companies, trends and opportunities are the subject of the 2009 report, "Worldwide Coronary Stents 2009,"  from MedMarket Diligence.
In 2009, drug-eluting stents (DES) command 60% of typical markets for coronary stents and, in some markets like China, the share is much higher.  Growth in the market for DES, at over 7%, is more than twice what it is for bare metal stents, since DES have demonstrated, through anti-restenosis, the ability to considerably reduced the need for repeat revascularization. The market for coronary stents will therefore continue to grow, penetrating deeper into bare metal stent markets and furthering the erosion of demand for the more invasive surgical alternative, coronary artery bypass grafting.
"The number of active companies and the size and growth of the market for coronary stents speaks to the intensity of development," says Patrick Driscoll of MedMarket Diligence, publisher of the report, 'Worldwide Coronary Stents Market, 2009'.  At least 75 companies are active in this arena, with current products on the market or at various stages of development.  Few avenues are being overlook in development, from stent material types, stent surface technology, drug-coating alternatives, drug-coating processes and others.  
Development of stent alternatives also includes bioabsorbable stents, which may be the likely successor to drug-eluting stents if they achieve the goal of providing revascularization with markedly better long-term clinical outcomes. Bioabsorbales under development may well enter some markets as soon as two years from now.  
Moreover, the premise of drug-eluting stents is being challenged through alternatives like drug-eluting balloon angioplasty and other device and non-device alternatives.  
The MedMarket Diligence report #C245 is described at http://www.mediligence.com/rpt/rpt-c245.htm and details the worldwide market for the use of alternative stent devices in the treatment of coronary artery disease.  The report assesses the treatment of coronary artery disease by alternative treatment methodologies (percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other medical/surgical treatment options), with estimated current/forecast caseload across treatment types. 
The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.
The report details currently approved coronary stents, providing data on current and forecast impact on the market.  The report also details the current state of product development in bare stents, drug-coated or drug-eluting stents and bioabsorbable stents in coronary applications and details the products under development, the anticipated timeline and impact of their market introduction.  The report assesses the current and ten-year forecast global market for coronary stents, with segmentation by U.S., Europe, Asia/Pacific and Rest of World.  The report provides competitor market shares by these geographic regions.  The leading and key emerging coronary stent manufacturers are profiled with current product offerings, development status and market strengths/advantages.

# # #

MedMarket Diligence provides data and insight to the medical products, investment and other industries on advanced medical technologies through focused medical technology market and assessment Reports and the Medtech Startups Database.